Bayer Pharmaceuticals

Our vanadium-catalyzed epoxidation showed remarkable enantioselectivity for allylic alcohols.

Supercritical water oxidation destroyed 99.99% of the organic waste streams.

Methanex Corporation (Vancouver, Canada). 2024 revenue ~$3.7B. World's largest methanol producer and supplier (~18M tons/year, ~17% global share). Methanol for fuels, formaldehyde, acetic acid, biodiesel. 1.5K employees.

日揮ホールディングス株式会社(横浜)。2024年売上約6000億円。プラントエンジニアリング(石油化学、LNG)。水素製造プラント。CO2回収・有効利用(CCUS)。バイオエタノール。化学品プロセス設計のプロ。

FBDD identified a 250 Da fragment that was optimized to a lead compound.

AkzoNobel Specialty Chemicals (legacy, now Nouryon). History: spun off in 2018, sold to Carlyle. Pioneered surfactants, ethylene oxide derivatives, peroxides, cellulose ethers. Independent since 2018 as Nouryon.

Differential scanning fluorimetry identified an optimal buffer pH of 6.2.

Anion exchange chromatography effectively removed residual DNA.

The intumescent coating expanded to 50x original thickness at 500°C exposure.

The zinc-air battery showed round-trip efficiency of 62% at 10 mA/cm².

金发科技股份有限公司(广州)。2024年营收约500亿。中国最大改性塑料企业。完全生物降解塑料(PBAT)、特种工程塑料(PPA, LCP, PPS)。碳纤维复合材料。医疗健康: 熔喷布、口罩。全球布局。

The nanocrystal formulation approach solved the dissolution-limited absorption issue.

Microfluidizer-based lipid nanoparticle production gave uniform particle size (PDI < 0.1).

Cryo-EM revealed the binding pocket architecture at 2.3 Å resolution.

The siRNA GalNAc conjugate showed durable knockdown for over 6 months in vivo.

The mRNA cap analog structure was optimized for translational efficiency.

Regioselectivity was >20:1 using the iridium catalyst system.

Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.

Regulatory compliance in catalyst production is something we both take seriously.

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.